Biotempt B.V.
Records under this name other than the patents Biotempt B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,288,341 | Control of radiation injury Lapsed on the fee record Ended Oct 16, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 16, 2024 | From the USPTO record |
| US 8,680,059 | Oligopeptide acetate and formulations thereof Lapsed on the fee record Ended Mar 25, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 25, 2022 | From the USPTO record |
| US 7,662,776 | Treatment of tumors using short peptides from human chorionic gonadotropin (HCG) Lapsed on the fee record Ended Feb 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2022 | From the USPTO record |
| US 7,786,084 | Treatment of burns Term ended Term ended Jan 23, 2022 · From the USPTO record | Term ended | Term ended Jan 23, 2022 | From the USPTO record |
| US 7,560,433 | Treatment of multiple sclerosis (MS) Lapsed on the fee record Ended Jul 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2021 | From the USPTO record |
| US 7,820,617 | Methods of selecting immunoregulator peptides obtained from gonadotropins Formerly held Term ended Term ended Jul 3, 2021 · From the USPTO record | Term ended | Term ended Jul 3, 2021 | From the USPTO record |
| US 7,524,820 | Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology Lapsed on the fee record Ended Apr 28, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 28, 2021 | From the USPTO record |
| US 7,517,529 | Treatment of type I diabetes Lapsed on the fee record Ended Apr 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2021 | From the USPTO record |
| US 7,501,391 | Treatment of transplant survival Lapsed on the fee record Ended Mar 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2021 | From the USPTO record |
| US 7,402,322 | Methods of treatment for septic shock with urine extract Formerly held Term ended Term ended Dec 20, 2020 · From the USPTO record | Term ended | Term ended Dec 20, 2020 | From the USPTO record |